MAPK3 and breast cancer: Consistently in this study, we noticed that when MDA-MB-231 and MCF-7 breast cancer cells were pretreated with AG1478, EGF-induced EGFR phosphorylation was blocked, and resulted in the inhibition of EGF-stimulated ERK1/2 phosphorylation and cell proliferation (data not shown).